Tiziana Life Sciences Ltd 0RP.F Stock
Tiziana Life Sciences Ltd Price Chart
Tiziana Life Sciences Ltd 0RP.F Financial and Trading Overview
| Tiziana Life Sciences Ltd stock price | 0.7 EUR |
| Previous Close | 0.68 EUR |
| Open | 0.71 EUR |
| Bid | 0.71 EUR x N/A |
| Ask | 0.73 EUR x N/A |
| Day's Range | 0.71 - 0.71 EUR |
| 52 Week Range | 0.47 - 1.15 EUR |
| Volume | 235 EUR |
| Avg. Volume | 12 EUR |
| Market Cap | 71.05M EUR |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.16 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
0RP.F Valuation Measures
| Enterprise Value | 50.14M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 3.6153846 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -3.438 |
Trading Information
Tiziana Life Sciences Ltd Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -11.53% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.15 EUR |
| 52 Week Low | 0.47 EUR |
| 50-Day Moving Average | 0.81 EUR |
| 200-Day Moving Average | 0.67 EUR |
0RP.F Share Statistics
| Avg. Volume (3 month) | 12 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 100.59M |
| Float | 56.14M |
| Short Ratio | N/A |
| % Held by Insiders | 43.00% |
| % Held by Institutions | 5.16% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:2 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -24.21% |
| Return on Equity (ttm) | -50.60% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -14585000 EUR |
| Net Income Avi to Common (ttm) | -15397000 EUR |
| Diluted EPS (ttm) | -0.14 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 18.12M EUR |
| Total Cash Per Share (mrq) | 0.18 EUR |
| Total Debt (mrq) | 365K EUR |
| Total Debt/Equity (mrq) | 1.87 EUR |
| Current Ratio (mrq) | 3.644 |
| Book Value Per Share (mrq) | 0.195 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -19615000 EUR |
| Levered Free Cash Flow (ttm) | -7930625 EUR |
Profile of Tiziana Life Sciences Ltd
| Country | Germany |
| State | N/A |
| City | London |
| Address | 14/15 Conduit Street |
| ZIP | W1S 2XJ |
| Phone | N/A |
| Website | https://www.tizianalifesciences.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 9 |
Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases. It also develops Milciclib (TZLS-201), a small molecule inhibitor of various cyclin-dependent kinases, tropomycin receptor kinases, and Src family kinases controlling cell growth and malignant progression of cancer; and anti- receptor (IL6R) mAb (TZLS-501), a fully human monoclonal antibody for the treatment of IL6-induced inflammation and to treat COVID-19 patients. Tiziana Life Sciences Ltd was incorporated in 1998 and is headquartered in London, the United Kingdom.Kingdom.
Q&A For Tiziana Life Sciences Ltd Stock
What is a current 0RP.F stock price?
Tiziana Life Sciences Ltd 0RP.F stock price today per share is 0.7 EUR.
How to purchase Tiziana Life Sciences Ltd stock?
You can buy 0RP.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Tiziana Life Sciences Ltd?
The stock symbol or ticker of Tiziana Life Sciences Ltd is 0RP.F.
Which industry does the Tiziana Life Sciences Ltd company belong to?
The Tiziana Life Sciences Ltd industry is Biotechnology.
How many shares does Tiziana Life Sciences Ltd have in circulation?
The max supply of Tiziana Life Sciences Ltd shares is 107.3M.
What is Tiziana Life Sciences Ltd Price to Earnings Ratio (PE Ratio)?
Tiziana Life Sciences Ltd PE Ratio is now.
What was Tiziana Life Sciences Ltd earnings per share over the trailing 12 months (TTM)?
Tiziana Life Sciences Ltd EPS is -0.16 EUR over the trailing 12 months.
Which sector does the Tiziana Life Sciences Ltd company belong to?
The Tiziana Life Sciences Ltd sector is Healthcare.